PubMed:8829135 / 277-502
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-225 | Sentence | denotes | Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 183 | 11-22 | ChemicalEntity | denotes | apomorphine | MESH:D001058 |
| 184 | 160-171 | ChemicalEntity | denotes | nefiracetam | MESH:C058876 |
| 185 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | MESH:D000647 |
| 186 | 204-224 | ChemicalEntity | denotes | dopaminergic agonism | MESH:D018491 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 78-94 | GeneOrGeneProduct | denotes | training or in a |
| T7 | 110-114 | GeneOrGeneProduct | denotes | post |
| T8 | 124-130 | GeneOrGeneProduct | denotes | period |
| T9 | 175-184 | GeneOrGeneProduct | denotes | attenuate |
| T10 | 193-200 | GeneOrGeneProduct | denotes | induced |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 110-114 | GeneOrGeneProduct | denotes | post |
| T4 | 124-130 | GeneOrGeneProduct | denotes | period |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T3 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | D000647 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 124-130 | GeneOrGeneProduct | denotes | period |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T4 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | 0001152 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T4 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | D000647 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T4 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | D000647 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T12 | 11-22 | ChemicalEntity | denotes | apomorphine | D001058|http://purl.obolibrary.org/obo/CHEBI_48538 |
| T14 | 160-171 | ChemicalEntity | denotes | nefiracetam | C058876|http://purl.obolibrary.org/obo/CHEBI_135004 |
| T16 | 204-224 | ChemicalEntity | denotes | dopaminergic agonism | ChemicalEntity |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T16 | 204-224 | ChemicalEntity | denotes | dopaminergic agonism | ChemicalEntity | |
| T14 | 160-171 | ChemicalEntity | denotes | nefiracetam | http://purl.obolibrary.org/obo/CHEBI_135004|C058876 | |
| T12 | 11-22 | ChemicalEntity | denotes | apomorphine | http://purl.obolibrary.org/obo/CHEBI_48538|D001058 | |
| T47990 | 124-130 | GeneOrGeneProduct | denotes | period | ||
| T53027 | 185-192 | DiseaseOrPhenotypicFeature | denotes | amnesia | D000647 |